Mateen Dalal currently works for healthcareopportunity.org as a content developer, writing valuable pieces pertaining to the healthcare industry. Having completed his graduation in electronics and telecommunication engineering, Mateen also boasts of a short-term experience in test engineering. When he isn’t penning down insightful pieces, Mateen spends time trekking across town and enjoying at the gaming zone. He can be contacted at- [email protected] | https://twitter.com/MateenDalal
Roche, a Swiss multinational healthcare company, has reportedly announced its plans to broaden breast cancer treatment with the newer breast cancer drug Kadcyla. The move comes in the wake …
The CHMP (Committee for Medicinal Products for Human Use), owned by the European Medicines Agency (EMA), has recommended approval for Praluent (alirocumab), a drug developed by Sanofi and the …
The investment will help support Solara Active’s expansion in its regulated markets and is expected to close in early 2019, subject to regulatory and shareholder approval. Renowned private equity …
The new drug has been found to be an effective analgesic without being addictive. Pfizer Inc., the leading American pharmaceutical corporation, and the global healthcare conglomerate, Eli Lilly & …
Lilly will leverage 111’s cloud-based solutions to be used in its e-prescription, online diagnosis, warehousing & distribution, patient services & support programs. 111, Inc., a leading integrated online & …
The ecosystem is anticipated to address healthcare industry challenges ranging from payment processing to promoting efficient claims. Health Care Service Corporation, Anthem, Aetna, IBM and PNC Bank recently announced …
BHVN received an approval letter from FDA to proceed its BHV-3241 clinical trial BHV-3241 is a novel MPO inhibitor developed for MSA treatment Biohaven has slated the Phase 3 …
Merck & Co. Inc. has reportedly inked a strategic collaboration agreement with Tencent Holdings Ltd., a Chinese firm providing internet value-added services. As per trusted sources, the collaboration is …
Biopharmaceutical company Achilles Therapeutics recently announced that it has received an approval from U.K. authorities for a Clinical Trial Application (CTA) to perform a Phase I/II study with a …
The study would focus on using the latest Apple Watch to detect atrial fibrillation (AFib), a leading cause of stroke. U.S. tech giant, Apple, Inc. is collaborating with pharmaceutical conglomerate, …
